Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream

McMaster University

$100,000.00

Understanding the role of mucosal epithelial barrier function in HIV pathogenesis

FY 2011-12

Summary
Clinical studies show that women are more susceptible to HIV-1 infection compared to men; but the reason for this difference is not well understood. HIV is transmitted in women primarily through sexual transmission, therefore it seems logical that in order to understand why women are more susceptible to this infection, we should try to understand the exact events that take place in the female genital tract leading up to establishment of HIV infection. Our recent studies have shown that when HIV first comes in contact with epithelial cells that line the mucosal surface of intestines as well as female genital tract, it causes inflammatory changes, leading to disruption of the mucosal barrier that is the body's primary defense against entry of HIV and other microbes found on the inner lining of the body. We found that this breach in the mucosal barrier can lead to leaking of both HIV as well as other bacteria across the epithelium. This could allow HIV to establish infection as well as cause chronic inflammation that is seen in HIV-infected individuals. With this knowledge, we recently tried to determine if treatment with immune factors, such as IL-22 cytokine that is known for its anti-inflammatory and restorative function in the intestine tract, could prevent disruption of mucosal barrier by HIV-1 in the female genital tract. Indeed, we found that if genital epithelial cells were treated with IL-22, they became resistant to inflammatory changes caused by HIV. In the current proposal, we propose to understand the underlying mechanism of how the mucosal barrier is disrupted by inflammatory factors and protected by IL-22 and whether this can be used as a prophylactic treatment to prevent HIV infection. This research will inform strategies to prevent HIV infection in women, in particular those who are at higher risk for HIV infection, such as women who have unprotected sex, immigrant African-Caribbean and Aboriginal women who have higher biological risk.
Program
Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
260358
Name
Kaushic Charu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Understanding the role of mucosal epithelial barrier function in HIV pathogenesis
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: HIV/AIDS Bridge Funding - Biomedical/Clinical Stream
Keyworddelim
Chronic Immune Activation; Epithelial Cells; Hiv; Innate Immune Responses; Mucosal Barrier; Mucosal Immunity; Primary Cell Cultures; Sexually Transmitted Diseases; Susceptibility; Women'S Reproductive Health
Abstract
Clinical studies show that women are more susceptible to HIV-1 infection compared to men; but the reason for this difference is not well understood. HIV is transmitted in women primarily through sexual transmission, therefore it seems logical that in order to understand why women are more susceptible to this infection, we should try to understand the exact events that take place in the female genital tract leading up to establishment of HIV infection. Our recent studies have shown that when HIV first comes in contact with epithelial cells that line the mucosal surface of intestines as well as female genital tract, it causes inflammatory changes, leading to disruption of the mucosal barrier that is the body's primary defense against entry of HIV and other microbes found on the inner lining of the body. We found that this breach in the mucosal barrier can lead to leaking of both HIV as well as other bacteria across the epithelium. This could allow HIV to establish infection as well as cause chronic inflammation that is seen in HIV-infected individuals. With this knowledge, we recently tried to determine if treatment with immune factors, such as IL-22 cytokine that is known for its anti-inflammatory and restorative function in the intestine tract, could prevent disruption of mucosal barrier by HIV-1 in the female genital tract. Indeed, we found that if genital epithelial cells were treated with IL-22, they became resistant to inflammatory changes caused by HIV. In the current proposal, we propose to understand the underlying mechanism of how the mucosal barrier is disrupted by inflammatory factors and protected by IL-22 and whether this can be used as a prophylactic treatment to prevent HIV infection. This research will inform strategies to prevent HIV infection in women, in particular those who are at higher risk for HIV infection, such as women who have unprotected sex, immigrant African-Caribbean and Aboriginal women who have higher biological risk.
Competitiondate
201203
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kaushic, Charu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~